Trial Profile
An observational prospective trial to evaluate the safety and efficacy of ezetimibe/simvastatin combination in kidney transplant patients with uncontrolled cholesterol levels
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2015
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 04 Nov 2015 New trial record
- 16 Sep 2015 Results presented at the 17th Congress of the European Society for Organ Transplantation